Skip to main content
  1. Home
  2. Emerging Tech
  3. Legacy Archives

Roombots: Scientists develop robots that can form different types of furniture

Add as a preferred source on Google

Are you ever at home and think to yourself you could really use another table right about now?  Soon, such an out-of-the-box wish may be at your command.

A team of Swiss researchers from Biorobotics Laboratory (BioRob) at École Polytechnique Fédérale de Lausanne (EPFL) have developed novel modular robots called Roombots, which can form any type of furniture at the drop of a hat.  The Lego-like robotic blocks move on their own and “stick” together, creating various structural shapes.

Recommended Videos

According to the researchers, they hope that one day, the Roombots will autonomously connect together to form everything from stools and chairs to sofas and tables.

“The idea of different units that self-assemble and change morphology has been around for quite a while, but nobody came up with a good idea for how to use them,” lead researcher Massimo Vespignani, an engineer at the École Polytechnique Fédérale de Lausanne, told LiveScience. Vespignani also co-authored an article on the research to be published in the July issue of the journal Robotics and Autonomous Systems.

Each Roombot is a 9-inch long block that contains a battery, an antenna, and three separate motors, which allow the module to move in three different dimensions and change its shape.  The blocks also house active connectors that can grip other modules and pieces of furniture, forming multiple types of structural configurations.  When strung together, the modules resemble a long robotic centipede.

The Roombots still have a long way to go before they can be available for public use, as the researchers still haven’t come up with a way for people to control them, and their current design cannot support a person’s weight.  But the scientists envision their modules being used for a number of applications, such as programmable conference rooms, satellite or space station elements, or assistive furniture for the elderly.

Loren Grush
Former Digital Trends Contributor
Loren Grush is a science and health writer living in New York City, having written for Fox News Health, Fox News SciTech and…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more